about bpl

Bio Products Laboratory Ltd.

News

BPL announces new vial size for Gammaplex®

BPL is pleased to announce that the MHRA has now approved a 20 g vial size for Gammaplex, BPL's intravenous immunoglobulin preparation.  The new 20 g vial size will offer users improved choice and convenience as fewer vial changes will be needed when 20 g or more ...

Date added: Tuesday 25th March 2014
Latest updated: Wednesday 8th February 2017

PRESS RELEASE - BPL's Supply of Factor X, XI and 8Y

London UK: Bio Products Laboratory (BPL) confirms to both the UK Department of Health and the Haemophilia Society that it has no intention to discontinue the manufacture and sales of Factor X (named patient), Factor XI (named patient) and 8Y (containing ADAMTS13).  BPL has assured ...

Date added: Friday 7th February 2014
Latest updated: Wednesday 8th February 2017

Change of name to BPL Holdings for Plasma Resources UK

The name change was announced today to BPL Holdings from Plasma Resources UK, the holding company for Bio Products Laboratory and DCI Biologicals. The change to BPL Holdings reflects the long-established name of Bio Products Laboratory, and will ensure wider customer recognition at a holding ...

Date added: Monday 13th January 2014
Latest updated: Wednesday 8th February 2017

BPL Announces: Strong progress on the world's first licensed Factor X product

London, UK - Bio Products Laboratory (BPL) is pleased to announce continued progress on what will be the world's first licensed Factor X concentrate.  The submission is ground-breaking; BPL's Factor X is the first pure factor X concentrate developed globally, and also the first treatment ...

Date added: Monday 4th November 2013
Latest updated: Wednesday 8th February 2017

BPL Investment Announcement to Customers

The United Kingdom's Department of Health has recently announced that Bain Capital acquired a controlling share of PRUK, the holding company for Bio Products Laboratory (BPL), with the Department of Health retaining a significant (20%) stake in the company. Bain Capital is one of the world's ...

Date added: Tuesday 17th September 2013
Latest updated: Wednesday 8th February 2017

PRESS RELEASE 18 July 2013

Press Notice - Minister welcomes Bain Capital buying majority stake in PRUK   Thursday 18th July, 2013   Health Minister Dr Dan Poulter has welcomed one of the world's leading investment firms acquiring a majority stake in Plasma Resources UK, which manufactures blood plasma products.   Bain Capital has bought 80 ...

Date added: Thursday 18th July 2013
Latest updated: Wednesday 8th February 2017

Patient information leaflets